WO2012105649A1 - Implement for surgery - Google Patents

Implement for surgery Download PDF

Info

Publication number
WO2012105649A1
WO2012105649A1 PCT/JP2012/052398 JP2012052398W WO2012105649A1 WO 2012105649 A1 WO2012105649 A1 WO 2012105649A1 JP 2012052398 W JP2012052398 W JP 2012052398W WO 2012105649 A1 WO2012105649 A1 WO 2012105649A1
Authority
WO
WIPO (PCT)
Prior art keywords
bioabsorbable
bone
filler
surgical instrument
bag body
Prior art date
Application number
PCT/JP2012/052398
Other languages
French (fr)
Japanese (ja)
Inventor
冨永 芳恵
武彦 中島
努 森原
恭男 笹井
奥原 信
聡 大村谷
Original Assignee
Hoya株式会社
アルフレッサファーマ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoya株式会社, アルフレッサファーマ株式会社 filed Critical Hoya株式会社
Priority to JP2012555954A priority Critical patent/JP5952198B2/en
Publication of WO2012105649A1 publication Critical patent/WO2012105649A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/68Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
    • A61B17/70Spinal positioners or stabilisers ; Bone stabilisers comprising fluid filler in an implant
    • A61B17/7097Stabilisers comprising fluid filler in an implant, e.g. balloon; devices for inserting or filling such implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/16Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
    • A61B17/1662Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans for particular parts of the body
    • A61B17/1671Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans for particular parts of the body for the spine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/441Joints for the spine, e.g. vertebrae, spinal discs made of inflatable pockets or chambers filled with fluid, e.g. with hydrogel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004(bio)absorbable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2217/00General characteristics of surgical instruments
    • A61B2217/002Auxiliary appliance
    • A61B2217/007Auxiliary appliance with irrigation system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/46Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
    • A61F2/4603Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof
    • A61F2/4611Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof of spinal prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2002/2817Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2002/2835Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
    • A61F2002/30006Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in density or specific weight
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
    • A61F2002/30032Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in absorbability or resorbability, i.e. in absorption or resorption time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30062(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/3008Properties of materials and coating materials radio-opaque, e.g. radio-opaque markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30092Properties of materials and coating materials using shape memory or superelastic materials, e.g. nitinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30535Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30581Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid
    • A61F2002/30583Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid filled with hardenable fluid, e.g. curable in-situ
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30535Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30581Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid
    • A61F2002/30588Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid filled with solid particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30535Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30604Special structural features of bone or joint prostheses not otherwise provided for modular
    • A61F2002/30616Sets comprising a plurality of prosthetic parts of different sizes or orientations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30682Means for preventing migration of particles released by the joint, e.g. wear debris or cement particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2002/4495Joints for the spine, e.g. vertebrae, spinal discs having a fabric structure, e.g. made from wires or fibres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00179Ceramics or ceramic-like structures
    • A61F2310/00185Ceramics or ceramic-like structures based on metal oxides
    • A61F2310/00203Ceramics or ceramic-like structures based on metal oxides containing alumina or aluminium oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00179Ceramics or ceramic-like structures
    • A61F2310/00185Ceramics or ceramic-like structures based on metal oxides
    • A61F2310/00221Ceramics or ceramic-like structures based on metal oxides containing calcia or calcium oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00179Ceramics or ceramic-like structures
    • A61F2310/00185Ceramics or ceramic-like structures based on metal oxides
    • A61F2310/00239Ceramics or ceramic-like structures based on metal oxides containing zirconia or zirconium oxide ZrO2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00179Ceramics or ceramic-like structures
    • A61F2310/00293Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00359Bone or bony tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00365Proteins; Polypeptides; Degradation products thereof

Definitions

  • the present invention relates to a surgical tool.
  • the treatment method is to fill the crushed vertebral body with a filling material via the pedicle (via the vertebral arch). There is.
  • the collapsed vertebral body is returned to its original shape, that is, a reduction operation is performed on the vertebral body.
  • the cavity formed in the vertebral body is filled with a filler such as a bone grafting material by such an operation, and prior to that, a mesh-like bag body capable of storing the bone grafting material is inserted into the cavity.
  • a filler such as a bone grafting material
  • a mesh-like bag body capable of storing the bone grafting material is inserted into the cavity.
  • the mesh openings are almost uniform, and depending on the size, it is conceivable that the bone prosthetic material leaks unintentionally from the bag. Further, it may be preferable that the bone filling material in the bag body is in contact with the bone as much as possible, but depending on the size of the opening, the bone filling material cannot be exposed from the pores of the mesh (bag body) and It is also possible that contact is impossible.
  • An object of the present invention is to provide a surgical tool that can prevent unintentional leakage of the filler from the bag body and that allows the filler in the bag to selectively contact a desired site of bone. It is in.
  • a surgical tool that is provided with a flexible bag body, inserted into a bone defect portion or a portion in contact with bone, and filled with a filling material in the inserted state in the inserted state. Because The bag is provided with a bioabsorbable portion having bioabsorbability at least in part, and a bioabsorbable portion in which absorption into the living body is suppressed or prevented.
  • the bag body is configured by a braided body formed in a mesh shape by intersecting a plurality of linear bodies.
  • the size of the opening of the braided body can be set as appropriate, so that it is possible to reliably prevent unintentional leakage of the filler from the bag body, and the filler in the bag body A desired site can be reliably and selectively contacted.
  • the contact area of the filler with the desired part of the bone increases with time, and the bonding force with the desired part of the bone also increases with time. Therefore, the surgical instrument filled with the filler is reliably stabilized in the bone defect portion.
  • the contact area of the filler with the desired part of the bone increases with time, and the bonding force with the desired part of the bone also increases with time. Therefore, the surgical instrument filled with the filler is more reliably stabilized in the bone defect.
  • Each of the linear bodies is composed of a stranded wire or a combined yarn obtained by twisting a plurality of strands,
  • the bag body has a mesh shape
  • the wire functioning as the bioabsorbable portion when the wire functioning as the bioabsorbable portion is absorbed in the living body, it contributes to an increase in the opening of the bag body. Thereby, a contact with the filler and bone
  • the bioabsorbable material is selected from the group consisting of polydioxanone, poly-L-lactide (PLLA), poly-D, L-lactide (PD, L-LA), polyglycolic acid, and polycaprolactone.
  • the surgical instrument according to (4) or (5) which is at least one kind. This ensures that the bioabsorbable part has bioabsorbability.
  • the bone in which the bone defect portion is formed or the portion in contact with the bone has a contactable portion that is desired to be brought into contact with the filler as much as possible and a contact deterrent portion that is desired to be prevented from being brought into contact with the filler as much as possible.
  • the filler can come into contact with the bone via the bioabsorbable part.
  • the filler in the bag can surely and selectively come into contact with a desired part of the bone.
  • the bioabsorbable portion can be reliably addressed to the target portion of the vertebral body, that is, the portion where the bioabsorbable portion is intended to be directed to the vertebral body.
  • the bioabsorbable portion is addressed to a desired site of the bone. Then, for a while after the operation, the filler is prevented or prevented from contacting the desired site, but after the bioabsorbable portion is absorbed, it can pass through the bag and contact the desired site. it can.
  • the filler in a bag body can contact
  • part are united and a surgical tool is reliably stabilized within a bone defect part.
  • unintentional leakage of the filler can be prevented at portions other than the bioabsorbable portion of the bag.
  • FIG. 1 is a perspective view showing a first embodiment of the surgical instrument of the present invention in a natural state (when not in use).
  • FIG. 2 is a perspective view showing an example of a usage state of the surgical instrument shown in FIG. 3 is a cross-sectional view taken along line AA in FIG. 2 (a cross-sectional view showing a change over time in the usage state of the surgical instrument shown in FIG. 1).
  • FIG. 4 is a cross-sectional view showing the change over time in the usage state of the surgical instrument of the present invention (second embodiment).
  • FIG. 5 is a graph showing the particle size distribution of the filler filled in the surgical instrument shown in FIG. FIG.
  • FIG. 6 is a diagram showing a change over time in the usage state of the linear body constituting the surgical instrument (third embodiment) of the present invention.
  • FIG. 7 is a perspective view showing a fourth embodiment in a natural state (when not in use) of the surgical instrument of the present invention.
  • FIG. 8 is a diagram for sequentially explaining a method of using the surgical instrument shown in FIG.
  • FIG. 9 is a view for sequentially explaining a method of using the surgical instrument shown in FIG.
  • FIG. 10 is a diagram for sequentially explaining a method of using the surgical instrument shown in FIG.
  • FIG. 11 is a diagram for sequentially explaining a method of using the surgical instrument shown in FIG. 1.
  • FIG. 12 is a diagram for sequentially explaining a method of using the surgical instrument shown in FIG.
  • FIG. 13 is a diagram for sequentially explaining a method of using the surgical instrument shown in FIG. 1.
  • FIG. 1 is a perspective view showing a first embodiment of the surgical tool of the present invention in a natural state (when not in use)
  • FIG. 2 is a perspective view showing an example of a usage state of the surgical tool shown in FIG. 2 is a cross-sectional view taken along line AA in FIG. 2 (cross-sectional view showing a change over time in the usage state of the surgical tool shown in FIG. 1)
  • FIGS. 8 to 13 are views of the surgical tool shown in FIG. It is a figure for demonstrating a usage method in order. 2 and FIGS. 8 to 13, the front side of the page is the “head side”, the back side of the page is the “leg side”, the upper side is the “belly side”, and the lower side is the “back side”.
  • the surgical instrument 1 is used by being inserted into a bone defect portion or a portion in contact with bone.
  • the bone defect refers to a bone cavity caused by a loss due to trauma, removal by removal surgery of a tumor or the like, a decrease in bone density due to osteoporosis or the like, or a combination of these factors.
  • connects a bone means the intervertebral etc. which are between vertebral bodies.
  • the surgical tool 1 is a craniofacial bone, intervertebral, clavicle, sternum, rib, carpal bone, metacarpal bone, hand phalange, sciatic bone, pubic bone, patella, tarsal bone, metatarsal bone, foot phalange.
  • the constituent material of the filler 8A is not particularly limited, and may be, for example, one or a combination of calcium phosphate compound, alumina, zirconia, polymer resin, and the like.
  • the filler 8A may be in any form such as a granule, a block, or a paste.
  • the surgical instrument 1 of the present embodiment has a flexible bag body 2 and a flexible body connected to the bag body 2. It is comprised with the tubular part 3 which has.
  • This surgical tool 1 can insert the bag 2 into the cavity (bone defect) 911 of the vertebral body 91 (see FIG. 12).
  • the surgical tool 1 is used by filling the lumen portion (internal space) 21 of the bag body 2 with a biocompatible filler 8A (see FIG. 13).
  • a state in which the bag body 2 is filled with the filler 8A is referred to as a “filled state”.
  • the filler 8A is a paste-like material having viscosity (fluidity) until the surgical tool 1 is filled. Thereby, the filling material 8A can be easily and reliably filled into the surgical instrument 1.
  • a syringe 10 can be used for filling the filler 8A as shown in FIG.
  • it does not specifically limit as 8 A of fillers For example, what has the following physical properties (consistency) is preferable. In an environment of 25 ° C., 1 [g] of the pasty filler 8A is placed on the glass plate, and a 120 [g] glass plate is gently stacked thereon.
  • the average value is preferably 10 to 40 [mm], more preferably 15 to 30 [mm].
  • Such a filler 8A is obtained by kneading a powder of a material used as a bone filling material (biological material) and a hardening liquid.
  • the “powder” here is a broad concept including powders, granules, fine flakes, needles, etc., and the shape, form, manufacturing method, etc. are not particularly limited.
  • a powder made of a calcium phosphate compound or the like is preferable.
  • Calcium phosphate compounds can be stably present in a living body for a long period of time, and are particularly excellent as a biomaterial.
  • Examples of calcium phosphate compounds include hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 ), TCP (Ca 3 (PO 4 ) 2 ), Ca 2 P 2 O 7 , Ca (PO 3 ) 2 , and Ca. 10 (PO 4 ) 6 F 2 , Ca 10 (PO 4 ) 6 Cl 2 , DCPD (CaHPO 4 .2H 2 O), Ca 4 O (PO 4 ) 2, etc., one or two of these The above can be mixed and used.
  • the average particle size of the powder is not particularly limited, but is usually preferably about 1 to 50 ⁇ m, more preferably about 4 to 30 ⁇ m.
  • liquid agent for example, the water for injection etc. are mentioned.
  • additives such as sodium chondroitin sulfate, disodium succinate anhydride, sodium hydrogen sulfite and the like may be added to the liquid agent.
  • the kneaded product (kneaded product) is cured with time to become a cured product.
  • the surgical tool 1 includes a bag body 2 and a tubular portion 3.
  • the bag body 2 is formed of a braided body formed in a mesh shape by intersecting a plurality of linear bodies 22.
  • the weaving method is not particularly limited, and examples include plain weaving, twill weaving, satin weaving, leash weaving, imitation weaving, knitting, warp knitting, sleeves, stitches, or a combination of these. It is done.
  • this mesh-shaped bag body 2 is not an essential requirement in the present invention, it is preferable to have a large opening portion 24 and a small opening portion 25 having different opening degrees. That is, it is preferable that the arrangement density of the pores 23 formed between the linear bodies 22 has a “sparse” portion and a “dense” portion.
  • the method for changing the size of the opening in the bag body 2 is not particularly limited. For example, the method for appropriately changing the above-described weaving method, the thickness of the linear body 22 is set smaller than that for the large opening portion 24.
  • the bag body 2 is not limited to a mesh shape, and may be a balloon shape.
  • the bag body 2 has a flat shape in the natural state shown in FIG. 1, and even in the use state shown in FIG. 2, that is, in a state in which the filler 8 ⁇ / b> A is filled, the bag body 2 expands to the flat shape. maintain.
  • the outer shape in the use state shown in FIG. 2 approximates the shape of the cavity 911 that is roughly determined in the vertebral body 91.
  • large opening portions 24 are arranged on both sides (vertical direction in FIG. 3) located in the thickness direction of the flat shape, and small opening portions 25 are arranged on the side surfaces (left and right direction in FIG. 3). Has been.
  • the bag body 2 directs the large opening portion 24 described later to the target portion of the vertebral body 91, that is, the large opening portion 24 with respect to the vertebral body 91.
  • the small opening portion 25 can be surely addressed to the desired portion, and the small opening portion 25 is surely directed to the other target portion of the vertebral body 91, that is, the portion where the small opening portion 25 is intended to be directed to the vertebral body 91. be able to.
  • the large opening portion 24 is a relatively large portion of the bag body 2 in the size of the opening, that is, the size of the pores 23.
  • the small opening portion 25 is a portion having a relatively small opening size in the bag body 2, that is, a portion having a smaller opening than the large opening portion 24.
  • the size relationship between the opening (pore 23) of the large opening portion 24 and the opening (pore 23) of the small opening portion 25 is, for example, the opening of the large opening portion 24 in a state before use.
  • the size of the (pore 23) is preferably 2 to 50 times the opening (pore 23) of the small opening portion 25, and more preferably 5 to 20 times.
  • the opening of the large opening portion 24 is preferably 0.05 to 9 mm, and more preferably 0.5 to 5 mm.
  • the opening of the small opening portion 25 is preferably 0.005 to 5 mm, and more preferably 0.1 to 1 mm.
  • the filler 8A Since the size of each opening of the large opening portion 24 and the small opening portion 25 is set as described above, the filler 8A is made of the large opening portion 24 as shown in FIG. Then, the passage from each of the pores 23 is reliably permitted, and the passage through each of the pores 23 is reliably prevented (or suppressed) in the small opening portion 25. Thereby, in the use state, the filler 8 ⁇ / b> A can preferentially contact the vertebral body 91 at the large opening portion 24 rather than the small opening portion 25. In other words, in the use state, the contact area of the filler 8A with the vertebral body 91 at the large opening portion 24 is larger than the contact area with the vertebral body 91 at the small opening portion 25.
  • the vertebral body 91 includes end plate bones (disk-like bones) 912 positioned in the vertical direction in a state where the human body is upright, and a side wall that connects the two end plate bones 912 and connects them. There is a bone 913 that constitutes it.
  • each end plate bone 912 (contactable portion) is desired to be brought into contact with the filler 8A as much as possible, and the bone 913 (contact deterring portion) constituting the side wall is filled with the filler. I want to suppress contact with 8A as much as possible.
  • the reason is that the bone 913 constituting the side wall is more likely to have a fracture line than the end plate bone, and when the fracture line is generated in the bone 913 constituting the side wall, the filler 8A leaked from the fracture line is This is because there is a risk of coming into contact with the spinal cord and nerve roots in the vicinity. Further, the reason for making contact between the end plate bone 912 and the filling material 8A is that if the contact is made, the filling material 8A and the end plate bone 912 are joined (healed), and the operation tool 1 in the filled state is obtained. This is because it can be stabilized in the cavity 911 of the vertebral body 91.
  • the surgical tool 1 has the shape as described above, so that the filler 8A can be inserted into the cavity 911 of the vertebral body 91 and filled with the filler 8A. 2 is spread from the inside, and the large opening portion 24 is surely addressed (appears) to the end plate bone 912, and the small opening portion 25 is surely addressed to the bone 913 constituting the side wall. (See FIG. 13).
  • the filler 8A passes through the pores 23 of the large opening portion 24 and comes into contact with the end plate bone 912. However, the small opening portion 25 is blocked from passing, and contact with the bone 913 constituting the side wall is prevented. This is prevented (see FIG. 3A).
  • the filler 8A in the bag body 2 preferentially contacts the end plate bone 912 of the vertebral body 91 and the end plate bone 912 (desired portion) of the bone 913 constituting the side wall. be able to.
  • the filling material 8A and the end plate bone 912 are fused, and the surgical tool 1 in the filled state is reliably stabilized in the cavity 911 of the vertebral body 91.
  • unintentional leakage of the filler 8A at the small openings 25 can be prevented. Thereby, it is possible to reliably prevent the filler 8A from coming into contact with the spinal cord in the bone (vertebral canal) constituting the side wall or the nerve root existing in the vicinity thereof.
  • the surgical tool 1 of the present invention includes a bioabsorbable part and a non-bioabsorbable part.
  • the size of the pores 23 may be substantially uniform over the entire bag body 2.
  • the bioabsorbable portion becomes a large opening portion 24 over time by being absorbed by the living body. Since the pores 23 can be set small in the initial stage of application of the affected area by becoming the large opening portion 24 with time, when a paste-like material is used as the filler 8A, the period until the paste is cured The leakage of the paste to the outside of the bag body 2 can be prevented. After the paste is cured, the bioabsorbable part, which is a desired part of the bag body 2, is absorbed.
  • the large opening portion 24 is made of a material having the whole (or at least 60% portion) having bioabsorbability (biodegradability), whereas the small opening portion 25 is made of the whole (or at least at least 60%).
  • 60% portion may be made of a material having non-biological absorbability that prevents or prevents absorption by the living body.
  • the material having bioabsorbability is not particularly limited, and examples thereof include poly-L-lactide (PLLA), poly-D-lactide (PDLA), and poly-D, L. -Lactide (PD, L-LA), polyglycolic acid, polycaprolactone, polydioxanone, L-lactide / glycolide copolymer, D-lactide / glycolide copolymer, L- and D-lactide / glycolide From copolymer (P (LA / GA)), L-lactide / caprolactone copolymer, D-lactide / caprolactone copolymer, L- and D-lactide / caprolactone copolymer (P (LA / CL)) At least one selected from the group can be used.
  • PLLA poly-L-lactide
  • PDLA poly-D-lactide
  • L-LA L. -Lactide
  • P (LA / GA) L-l
  • both (or one) of the two linear bodies 22 intersecting each other that knitting the large opening portion 24 can be formed of the first material.
  • each linear body 22 of the large opening portion 24 is decomposed and absorbed with time, and finally disappears.
  • the size of each pore 23 increases by the amount that each linear body 22 is decomposed and absorbed.
  • the contact area of the filling material 8A with the end plate bone 912 of the vertebral body 91 increases with time, and accordingly, the vertebral body 91 has a contact area.
  • the joining force with the end plate bone 912 also increases with time. As a result, the filled surgical instrument 1 is more reliably stabilized in the cavity 911 of the vertebral body 91.
  • the large opening portion 24 is configured to satisfy such a demand.
  • the large opening portion 24 is a portion in the bag body 2 that also serves as a “bioabsorbing portion” that is absorbed by the living body (functions as a “bioabsorbing portion”).
  • the change with time of the size of the opening of the large opening portion 24 is preferably increased at a rate of 0.1 to 5% / day, for example. Whether or not such a setting is made is determined by, for example, impregnating a sample of the “large opening portion 24” with a simulated body fluid (SBF (Simulated Body Fluid)) or physiological saline, and changing the opening of the sample. This can be confirmed by observation.
  • a simulated body fluid Simulated Body Fluid
  • the material (hereinafter referred to as “second material”) that is inhibited or prevented from being absorbed by the living body is not particularly limited.
  • both of the two linear bodies 22 intersecting each other that knitting the small opening portion 25 can be made of the second material. As a result, as shown in FIGS.
  • each linear body 22 of the small opening portion 25 is decomposed with time like each linear body 22 of the large opening portion 24 even in use. ⁇ It is surely prevented from being absorbed. As a result, the size of the pores 23 of the small openings 25 is kept constant, and thus the filler 8A is prevented from leaking unintentionally and coming into contact with the bone 913 constituting the side wall of the vertebral body 91. The state can persist.
  • the small opening portion 25 is a portion of the bag body 2 that also serves as a “living body non-absorbing portion” in which absorption into the living body is suppressed or prevented (functions as a “living body non-absorbing portion”). Can do.
  • the tubular portion 3 is connected to the small opening portion 25 of the bag body 2.
  • the tubular portion 3 has a pipe line (hollow portion) 31 communicating with the lumen portion 21 of the bag body 2.
  • the conduit 31 functions as a flow path through which the filler 8A passes when the lumen 8 of the bag 2 is filled with the filler 8A. Thereby, the bag 8 can be filled with the filler 8A easily and reliably.
  • the tubular portion 3 has a mesh shape.
  • the opening of the tubular portion 3 is set to be smaller than the opening of the small opening portion 25, and is preferably 0.1 to 1 times the opening of the small opening portion 25, for example.
  • the constituent material of the tubular portion 3 is not particularly limited, but for example, the same material as the constituent material of the small opening portion 25 can be used. Thereby, the bag body 2 and the tubular part 3 can be manufactured collectively with a knitting machine.
  • the rasp 50 is inserted into one hole 93 to clean the cavity 911 of the vertebral body 91 and reduce the vertebral body 91.
  • a syringe 60 preliminarily filled with physiological saline Q is prepared. Then, as shown in FIG. 11, the mouth 601 of the syringe 60 is inserted into one hole 93, and in this state, physiological saline Q is injected into the cavity 911 of the vertebral body 91. This injection operation is performed until the physiological saline Q is discharged from the other hole 93. Thereby, the cavity 911 of the vertebral body 91 is cleaned.
  • the bag 2 of the surgical tool 1 is inserted into the cavity 911 of the vertebral body 91 from one hole 93 using, for example, an insertion guide rod 70. At this time, the tubular portion 3 of the surgical instrument 1 is positioned in the one hole 93.
  • a syringe 10 preliminarily filled with the filler 8A is prepared. And as shown in FIG. 13, the opening
  • FIG. 4 is a cross-sectional view showing a change over time in the usage state of the surgical instrument of the present invention (second embodiment), and FIG. 5 shows the particle size distribution of the filler filled in the surgical instrument shown in FIG. It is a graph.
  • the filler 8 ⁇ / b> B is composed of a plurality of granules 81.
  • granule is a broad concept including powders, particles, fine flakes, blocks, needles, and the like, and the shape, form, production method, and the like are not particularly limited.
  • each granule 81 is made of, for example, the same material as the powder constituting the filler 8A in the first embodiment.
  • the average particle diameter d of the granules 81 is not particularly limited, but is preferably 0.1 to 10 mm, for example, and more preferably 1 to 5 mm.
  • the opening of the large opening portion 24 and the opening of the small opening portion 25 are each smaller than the average particle diameter d in a state before use.
  • the opening of the large opening portion 24 is preferably 0.5 to 0.9 times the average particle diameter d.
  • the opening of the small openings 25 is preferably 0.05 to 0.5 times the average particle diameter d.
  • FIG. 6 is a diagram showing a change over time in the usage state of the linear body constituting the surgical instrument (third embodiment) of the present invention.
  • the third embodiment of the surgical instrument of the present invention will be described with reference to this figure, but the description will focus on the differences from the above-described embodiment, and the description of the same matters will be omitted.
  • the present embodiment is the same as the first embodiment except that the configuration of the linear body is different.
  • each linear body 22 in the large opening portion 24 is composed of a stranded wire formed by twisting a strand 221 and a strand 222.
  • each linear body 22 may be a combined yarn including a bundle of a plurality of yarns that are not twisted.
  • the strand 221 is comprised with the 1st material (material which has bioabsorbability) mentioned above.
  • the strand 221 functions as a bioabsorbing part, and contributes to the increase in opening.
  • the strand 222 is comprised with the 2nd material (material in which absorption to a biological body is suppressed or prevented).
  • the number of the strands which respectively comprise each linear body 22 in the large opening part 24 is two in this embodiment, it is not limited to this, For example, three or more may be sufficient. In this case, at least one strand can be made of a bioabsorbable material.
  • FIG. 7 is a perspective view showing a fourth embodiment in a natural state (when not in use) of the surgical instrument of the present invention.
  • This embodiment is the same as the first embodiment except that the configuration of the bag body of the surgical tool is different.
  • the bag 2 is provided with a marker portion 26 that can be viewed under X-ray fluoroscopy.
  • An installation form of the marker portion 26 is not particularly limited, and for example, a form in which a metal wire made of a Ni—Ti superelastic alloy is knitted into the linear body 22 is exemplified.
  • Other forms include contrast agents such as barium sulfate, barium fluoride, and barium silicate, bismuth compounds, zirconium compounds, lanthanum compounds, thorium compounds, and rare earth metals, etc. There is also a form of knitting a method).
  • the marker part 26 can be provided with contrast, and therefore the installation state of the bag body 2 in the cavity 911 of the vertebral body 91 can be grasped under X-ray fluoroscopy.
  • the arrangement position of the marker portion 26 is not particularly limited, but is preferably a boundary portion between the large opening portion 24 (biological absorption portion) and the small opening portion 25 (biological non-absorption portion), for example. This makes it possible to check whether the bag body 2 is installed at an appropriate position and direction in the body even during compensation and during follow-up after surgery.
  • the marker part 26 may be arrange
  • the surgical tool of the present invention may be a combination of any two or more configurations (features) of the above embodiments.
  • the bag may have a uniform opening throughout.
  • the bag body may contain a substance that promotes bone fusion, such as hydroxyapatite, BMP, and TGF.
  • the bioabsorbable portion is addressed to a desired site of the bone. Then, for a while after the operation, the filler is prevented or prevented from contacting the desired site, but after the bioabsorbable portion is absorbed, it can pass through the bag and contact the desired site. it can.
  • the filler in a bag body can contact
  • part are united and a surgical tool is reliably stabilized within a bone defect part.
  • unintentional leakage of the filler can be prevented at portions other than the bioabsorbable portion of the bag. Therefore, the present invention has industrial applicability.

Abstract

An implement (1) for surgery is provided with a flexible pouch (2) and is used as follows: said pouch (2) is inserted into a cavity (911) in a vertebral body (91), and with the pouch inserted, the inside of the pouch (2) is filled with a filler (8A). The pouch (2) is provided with a bioabsorbable coarse-mesh part (24) and a non-bioabsorbable fine-mesh part (25) for which absorption into the body is inhibited or prevented. The present invention makes it possible to both prevent unintended leakage of the filler (8A) from inside the pouch (2) and allow the filler (8A) in the pouch (2) to selectively contact a desired area of the bone.

Description

手術用具Surgical tools
 本発明は、手術用具に関する。 The present invention relates to a surgical tool.
 外傷や骨粗鬆症等により椎体が潰れる、いわゆる椎体圧迫骨折の治療法の一つとして、圧潰した椎体内に、経椎弓根的に(椎弓を介して)充填材を充填する治療法がある。 As a treatment method for so-called vertebral body compression fractures, in which the vertebral body collapses due to trauma, osteoporosis, etc., the treatment method is to fill the crushed vertebral body with a filling material via the pedicle (via the vertebral arch). There is.
 この治療法では、まず、圧潰した椎体をほぼ元の形状に戻すこと、すなわち、椎体に整復操作を施す。その後、かかる操作により椎体内に形成された空洞に骨補填材のような充填材を充填するが、それに先行して、前記空洞に骨補填材を収納可能なメッシュ状の袋体を挿入する(例えば、特許文献1参照)。そして、この前記空洞に挿入された袋体に骨補填材を充填することが行われる。 In this treatment method, first, the collapsed vertebral body is returned to its original shape, that is, a reduction operation is performed on the vertebral body. Thereafter, the cavity formed in the vertebral body is filled with a filler such as a bone grafting material by such an operation, and prior to that, a mesh-like bag body capable of storing the bone grafting material is inserted into the cavity. (For example, refer to Patent Document 1). Then, filling the bone filling material into the bag inserted into the cavity is performed.
 しかしながら、特許文献1に記載の袋体では、メッシュの目開きがほぼ均一となっており、その大きさによっては、骨補填材が袋体から不本意に漏出することが考えられる。また、袋体内の骨補填材は、できる限り骨と接するのが好ましい場合があるが、目開きの大きさによっては、メッシュ(袋体)の細孔から露出することができずに骨との接触が不可能となることも考えられる。 However, in the bag described in Patent Document 1, the mesh openings are almost uniform, and depending on the size, it is conceivable that the bone prosthetic material leaks unintentionally from the bag. Further, it may be preferable that the bone filling material in the bag body is in contact with the bone as much as possible, but depending on the size of the opening, the bone filling material cannot be exposed from the pores of the mesh (bag body) and It is also possible that contact is impossible.
特表2005-527295号公報JP 2005-527295 Gazette
 本発明の目的は、袋体内からの充填材の不本意な漏出を防止することができるとともに、袋体内の充填材が骨の所望の部位に選択的に接することができる手術用具を提供することにある。 An object of the present invention is to provide a surgical tool that can prevent unintentional leakage of the filler from the bag body and that allows the filler in the bag to selectively contact a desired site of bone. It is in.
 このような目的は、下記(1)~(10)の本発明により達成される。
 (1) 可撓性を有する袋体を備え、該袋体を骨欠損部あるいは骨と接する部位に挿入し、その挿入状態で前記袋体の内部に充填材を充填して使用される手術用具であって、
 前記袋体は、その少なくとも一部に生体吸収性を有する生体吸収部と、生体への吸収が抑止または防止された生体非吸収部とを備えることを特徴とする手術用具。
Such an object is achieved by the present inventions (1) to (10) below.
(1) A surgical tool that is provided with a flexible bag body, inserted into a bone defect portion or a portion in contact with bone, and filled with a filling material in the inserted state in the inserted state. Because
The bag is provided with a bioabsorbable portion having bioabsorbability at least in part, and a bioabsorbable portion in which absorption into the living body is suppressed or prevented.
 これにより、袋体内からの充填材の不本意な漏出を防止することができるとともに、袋体内の充填材が骨の所望の部位に選択的に接することができる。 Thereby, unintentional leakage of the filler from the bag body can be prevented, and the filler in the bag body can selectively contact a desired part of the bone.
 (2) 前記袋体は、複数本の線状体を交差させてメッシュ状に形成した編組体で構成されたものである上記(1)に記載の手術用具。 (2) The surgical tool according to (1), wherein the bag body is configured by a braided body formed in a mesh shape by intersecting a plurality of linear bodies.
 これにより、編組体の目開きの大きさを適宜設定することができ、よって、袋体内からの充填材の不本意な漏出を確実に防止することができるとともに、袋体内の充填材が骨の所望の部位に確実に選択的に接することができる。 As a result, the size of the opening of the braided body can be set as appropriate, so that it is possible to reliably prevent unintentional leakage of the filler from the bag body, and the filler in the bag body A desired site can be reliably and selectively contacted.
 (3) 前記袋体は、使用状態で経時的に前記生体吸収部での目開きが増大する上記(2)に記載の手術用具。 (3) The surgical instrument according to (2), wherein the opening of the bioabsorbable portion increases with time in the use state of the bag.
 これにより、充填材は、骨の所望の部位との接触面積が経時的に増大し、これに伴って骨の所望の部位との接合力も経時的に増大することとなる。よって、充填材が充填された状態の手術用具が骨欠損部内で確実に安定する。 Thereby, the contact area of the filler with the desired part of the bone increases with time, and the bonding force with the desired part of the bone also increases with time. Therefore, the surgical instrument filled with the filler is reliably stabilized in the bone defect portion.
 (4) 互いに交差する2本の前記線状体のうちの少なくとも一方は、生体吸収性材料で構成され、前記生体吸収部として機能する上記(2)または(3)に記載の手術用具。 (4) The surgical instrument according to (2) or (3), wherein at least one of the two linear bodies intersecting each other is made of a bioabsorbable material and functions as the bioabsorbable part.
 これにより、充填材は、骨の所望の部位との接触面積が経時的に増大し、これに伴って骨の所望の部位との接合力も経時的に増大することとなる。よって、充填材が充填された状態の手術用具が骨欠損部内でより確実に安定する。 Thereby, the contact area of the filler with the desired part of the bone increases with time, and the bonding force with the desired part of the bone also increases with time. Therefore, the surgical instrument filled with the filler is more reliably stabilized in the bone defect.
 (5) 前記各線状体は、それぞれ、複数の素線を撚り合わせてなる撚り線もしくは合糸で構成されており、
 前記複数の素線のうちの少なくとも1本は、生体吸収性材料で構成され、前記生体吸収部として機能する上記(2)または(3)に記載の手術用具。
(5) Each of the linear bodies is composed of a stranded wire or a combined yarn obtained by twisting a plurality of strands,
The surgical instrument according to (2) or (3), wherein at least one of the plurality of strands is made of a bioabsorbable material and functions as the bioabsorbable portion.
 例えば袋体がメッシュ状をなすものである場合には、生体吸収部として機能する素線が生体内で吸収されると、袋体の目開きの増大に寄与する。これにより、生体吸収部での充填材と骨との接触が促進される。 For example, in the case where the bag body has a mesh shape, when the wire functioning as the bioabsorbable portion is absorbed in the living body, it contributes to an increase in the opening of the bag body. Thereby, a contact with the filler and bone | frame in a bioabsorption part is accelerated | stimulated.
 (6) 前記生体吸収性材料は、ポリジオキサノン、ポリ-L-ラクチド(PLLA)、ポリ-D,L-ラクチド(P-D,L-LA)、ポリグリコール酸、ポリカプロラクトンからなる群から選択された少なくとも1種である上記(4)または(5)に記載の手術用具。
 これにより、生体吸収部が確実に生体吸収性を有するものとなる。
(6) The bioabsorbable material is selected from the group consisting of polydioxanone, poly-L-lactide (PLLA), poly-D, L-lactide (PD, L-LA), polyglycolic acid, and polycaprolactone. The surgical instrument according to (4) or (5), which is at least one kind.
This ensures that the bioabsorbable part has bioabsorbability.
 (7) 前記骨欠損部が形成された骨または骨と接する前記部位には、前記充填材とできるだけ接触させたい接触可能部と、前記充填材との接触をできるだけ抑止したい接触抑止部とがあり、
 前記接触可能部には、前記生体吸収部が宛がわれ、前記接触抑止部には、前記生体非吸収部が宛がわれる上記(1)ないし(6)のいずれかに記載の手術用具。
(7) The bone in which the bone defect portion is formed or the portion in contact with the bone has a contactable portion that is desired to be brought into contact with the filler as much as possible and a contact deterrent portion that is desired to be prevented from being brought into contact with the filler as much as possible. ,
The surgical instrument according to any one of (1) to (6), wherein the bioabsorbable portion is addressed to the contactable portion, and the bioabsorbable portion is addressed to the contact suppression portion.
 これにより、充填材は、生体吸収部を介して、骨と接することができる。このように、本発明の手術用具では、袋体内の充填材が骨の所望の部位に確実に選択的に接することができる。 Thereby, the filler can come into contact with the bone via the bioabsorbable part. As described above, in the surgical instrument of the present invention, the filler in the bag can surely and selectively come into contact with a desired part of the bone.
 (8) 前記袋体は、扁平形状をなし、その両面側にそれぞれ前記生体吸収部が配置され、側面側に前記生体非吸収部が配置されている上記(1)ないし(7)のいずれかに記載の手術用具。 (8) Any of the above (1) to (7), wherein the bag body has a flat shape, the bioabsorbable portion is disposed on both sides thereof, and the bioabsorbable portion is disposed on the side surface side. The surgical tool according to 1.
 これにより、例えば椎体に本発明の手術用具を使用する場合、生体吸収部を椎体の目的部位、すなわち、椎体に対し生体吸収部を宛がいたい部分に確実に宛がうことができる。 As a result, for example, when the surgical instrument of the present invention is used for the vertebral body, the bioabsorbable portion can be reliably addressed to the target portion of the vertebral body, that is, the portion where the bioabsorbable portion is intended to be directed to the vertebral body. .
 (9) 前記袋体は、X線透視下で視認可能なマーカ部を備える上記(1)ないし(8)のいずれかに記載の手術用具。
 これにより、骨欠損部での袋体の設置状態をX線透視下で把握することができる。
(9) The surgical tool according to any one of (1) to (8), wherein the bag body includes a marker portion that is visible under X-ray fluoroscopy.
Thereby, the installation state of the bag body in the bone defect part can be grasped under X-ray fluoroscopy.
 (10) 前記マーカ部は、前記生体吸収部と前記生体非吸収部との境界部に配置されている上記(9)に記載の手術用具。 (10) The surgical instrument according to (9), wherein the marker portion is disposed at a boundary portion between the living body absorbing portion and the living body non-absorbing portion.
 これにより、術時においては、袋体の内部が密になるように充填材を導入することが容易になり、術後においては、経過観察が容易になる。 This makes it easy to introduce the filler so that the inside of the bag is dense during surgery, and facilitates follow-up after surgery.
 本発明によれば、袋体を骨欠損部に挿入して当該袋体に充填材を充填することにより、生体吸収部が骨の所望の部位に宛がわれることとなる。そして、充填材は、術後しばらくは、前記所望の部位との接触が抑止または防止されるが、生体吸収部が吸収された後、袋体を通過して、前記所望の部位と接することができる。このように、本発明では、袋体内の充填材が前記所望の部位に優先的に接することができる。これにより、充填材と前記所望の部位とが癒合して、手術用具が骨欠損部内で確実に安定する。また、袋体の生体吸収部以外の部分では、充填材の不本意な漏出を防止することができる。 According to the present invention, by inserting the bag body into the bone defect portion and filling the bag body with the filler, the bioabsorbable portion is addressed to a desired site of the bone. Then, for a while after the operation, the filler is prevented or prevented from contacting the desired site, but after the bioabsorbable portion is absorbed, it can pass through the bag and contact the desired site. it can. Thus, in this invention, the filler in a bag body can contact | abut preferentially the said desired site | part. Thereby, a filler and the said desired site | part are united and a surgical tool is reliably stabilized within a bone defect part. In addition, unintentional leakage of the filler can be prevented at portions other than the bioabsorbable portion of the bag.
図1は、本発明の手術用具の自然状態(未使用時)での第1実施形態を示す斜視図である。FIG. 1 is a perspective view showing a first embodiment of the surgical instrument of the present invention in a natural state (when not in use). 図2は、図1に示す手術用具の使用状態の一例を示す斜視図である。FIG. 2 is a perspective view showing an example of a usage state of the surgical instrument shown in FIG. 図3は、図2中のA-A線断面図(図1に示す手術用具の使用状態での経時的な変化を示す断面図)である。3 is a cross-sectional view taken along line AA in FIG. 2 (a cross-sectional view showing a change over time in the usage state of the surgical instrument shown in FIG. 1). 図4は、本発明の手術用具(第2実施形態)の使用状態での経時的な変化を示す断面図である。FIG. 4 is a cross-sectional view showing the change over time in the usage state of the surgical instrument of the present invention (second embodiment). 図5は、図4に示す手術用具に充填される充填材の粒度分布を示すグラフである。FIG. 5 is a graph showing the particle size distribution of the filler filled in the surgical instrument shown in FIG. 図6は、本発明の手術用具(第3実施形態)を構成する線状体の使用状態での経時的な変化を示す図である。FIG. 6 is a diagram showing a change over time in the usage state of the linear body constituting the surgical instrument (third embodiment) of the present invention. 図7は、本発明の手術用具の自然状態(未使用時)での第4実施形態を示す斜視図である。FIG. 7 is a perspective view showing a fourth embodiment in a natural state (when not in use) of the surgical instrument of the present invention. 図8は、図1に示す手術用具の使用方法を順に説明するための図である。FIG. 8 is a diagram for sequentially explaining a method of using the surgical instrument shown in FIG. 図9は、図1に示す手術用具の使用方法を順に説明するための図である。FIG. 9 is a view for sequentially explaining a method of using the surgical instrument shown in FIG. 図10は、図1に示す手術用具の使用方法を順に説明するための図である。FIG. 10 is a diagram for sequentially explaining a method of using the surgical instrument shown in FIG. 図11は、図1に示す手術用具の使用方法を順に説明するための図である。FIG. 11 is a diagram for sequentially explaining a method of using the surgical instrument shown in FIG. 1. 図12は、図1に示す手術用具の使用方法を順に説明するための図である。FIG. 12 is a diagram for sequentially explaining a method of using the surgical instrument shown in FIG. 図13は、図1に示す手術用具の使用方法を順に説明するための図である。FIG. 13 is a diagram for sequentially explaining a method of using the surgical instrument shown in FIG. 1.
 以下、本発明の手術用具を添付図面に示す好適な実施形態に基づいて詳細に説明する。
 <第1実施形態>
  図1は、本発明の手術用具の自然状態(未使用時)での第1実施形態を示す斜視図、図2は、図1に示す手術用具の使用状態の一例を示す斜視図、図3は、図2中のA-A線断面図(図1に示す手術用具の使用状態での経時的な変化を示す断面図)、図8~図13は、それぞれ、図1に示す手術用具の使用方法を順に説明するための図である。なお、図2、図8~図13中、紙面手前側が「頭側」、紙面奥側が「脚側」、上側が「腹側」、下側が「背側」となっている。
Hereinafter, the surgical instrument of the present invention will be described in detail based on preferred embodiments shown in the accompanying drawings.
<First Embodiment>
FIG. 1 is a perspective view showing a first embodiment of the surgical tool of the present invention in a natural state (when not in use), FIG. 2 is a perspective view showing an example of a usage state of the surgical tool shown in FIG. 2 is a cross-sectional view taken along line AA in FIG. 2 (cross-sectional view showing a change over time in the usage state of the surgical tool shown in FIG. 1), and FIGS. 8 to 13 are views of the surgical tool shown in FIG. It is a figure for demonstrating a usage method in order. 2 and FIGS. 8 to 13, the front side of the page is the “head side”, the back side of the page is the “leg side”, the upper side is the “belly side”, and the lower side is the “back side”.
 図2、図12、図13に示すように、手術用具1は、骨欠損部あるいは骨と接する部位に挿入して使用されるものである。ここで、骨欠損部とは、外傷による喪失、腫瘍等の除去手術による除去、骨粗鬆症等による骨密度の低下等、または、これらの複合的な要因により生じた骨の空洞部のことを言う。また、骨と接する部位とは、椎体と椎体の間である椎間等のことを言う。 As shown in FIG. 2, FIG. 12, and FIG. 13, the surgical instrument 1 is used by being inserted into a bone defect portion or a portion in contact with bone. Here, the bone defect refers to a bone cavity caused by a loss due to trauma, removal by removal surgery of a tumor or the like, a decrease in bone density due to osteoporosis or the like, or a combination of these factors. Moreover, the site | part which contact | connects a bone means the intervertebral etc. which are between vertebral bodies.
 また、手術用具1は、頭蓋顎顔面骨、椎間、鎖骨、胸骨、肋骨、手根骨、中手骨、手の指骨、坐骨、恥骨、膝蓋骨、足根骨、中足骨、足の指骨、椎体、腸骨、肩甲骨、上腕骨、尺骨、橈骨、大腿骨、脛骨および腓骨からなる群より選択される少なくとも1種の骨の骨欠損部あるいは骨と接する部位に好適に使用される。これらの骨は、比較的大きいサイズ(寸法)の骨であり、このような骨の骨欠損部に、手術用具1は、充填材8Aを効率よくかつ高い充填率で充填して使用することができる。充填材8Aの構成材料としては、特に限定されず、例えば、リン酸カルシウム系化合物、アルミナ、ジルコニア、高分子樹脂などの1種またはそれらの組合せであってもよい。また、充填材8Aは、顆粒状、ブロック状、ペースト状などのいずれの形態にしてもよい。 In addition, the surgical tool 1 is a craniofacial bone, intervertebral, clavicle, sternum, rib, carpal bone, metacarpal bone, hand phalange, sciatic bone, pubic bone, patella, tarsal bone, metatarsal bone, foot phalange. Vertebral body, iliac bone, scapula, humerus, ulna, radius, femur, tibia, and at least one type of bone selected from the group consisting of the ribs or a site in contact with the bone. . These bones are bones of relatively large size (dimensions), and the surgical instrument 1 can be used by efficiently filling the bone defect portion of such bones with the filling material 8A at a high filling rate. it can. The constituent material of the filler 8A is not particularly limited, and may be, for example, one or a combination of calcium phosphate compound, alumina, zirconia, polymer resin, and the like. The filler 8A may be in any form such as a granule, a block, or a paste.
 以下では、椎体が圧潰した際に、この椎体の修復を行う手技(椎体圧迫骨折整復術)に、手術用具1を適用する場合について代表的に説明する。 Hereinafter, a case where the surgical tool 1 is applied to a technique for repairing a vertebral body when the vertebral body is crushed (vertebral body compression fracture reduction) will be described.
 図1(図2、図12、図13についても同様)に示すように、本実施形態の手術用具1は、可撓性を有する袋体2と、袋体2に接続された可撓性を有する管状部3とで構成されている。この手術用具1は、袋体2を椎体91の空洞(骨欠損部)911に挿入することができる(図12参照)。そして、その挿入状態で、手術用具1は、袋体2の内腔部(内部空間)21に、生体親和性を有する充填材8Aを充填して使用される(図13参照)。以下、袋体2内に充填材8Aが充填された状態を「充填状態」と言う。 As shown in FIG. 1 (the same applies to FIGS. 2, 12, and 13), the surgical instrument 1 of the present embodiment has a flexible bag body 2 and a flexible body connected to the bag body 2. It is comprised with the tubular part 3 which has. This surgical tool 1 can insert the bag 2 into the cavity (bone defect) 911 of the vertebral body 91 (see FIG. 12). In the inserted state, the surgical tool 1 is used by filling the lumen portion (internal space) 21 of the bag body 2 with a biocompatible filler 8A (see FIG. 13). Hereinafter, a state in which the bag body 2 is filled with the filler 8A is referred to as a “filled state”.
 まず、充填材8Aについて説明する。
 充填材8Aは、手術用具1に充填されるまでは粘性(流動性)を有するペースト状のものである。これにより、充填材8Aを手術用具1に容易にかつ確実に充填することができる。なお、充填材8Aの充填には、例えば図13に示すように、シリンジ10を用いることができる。また、充填材8Aとしては、特に限定されず、例えば、以下の物性(稠度)を有するものが好ましい。25℃の環境下で1[g]のペースト状の充填材8Aをガラス板上に載置し、その上から120[g]のガラス板を静かに重ねる。そして、このときに広がった充填材8Aの最大幅を有する部分の長さと最小幅を有する部分の長さとを測定し、これらの平均値を算出する。その平均値は、10~40[mm]が好ましく、15~30[mm]がより好ましい。
First, the filler 8A will be described.
The filler 8A is a paste-like material having viscosity (fluidity) until the surgical tool 1 is filled. Thereby, the filling material 8A can be easily and reliably filled into the surgical instrument 1. For example, a syringe 10 can be used for filling the filler 8A as shown in FIG. Moreover, it does not specifically limit as 8 A of fillers, For example, what has the following physical properties (consistency) is preferable. In an environment of 25 ° C., 1 [g] of the pasty filler 8A is placed on the glass plate, and a 120 [g] glass plate is gently stacked thereon. Then, the length of the portion having the maximum width and the length of the portion having the minimum width of the filler 8A spread at this time are measured, and an average value thereof is calculated. The average value is preferably 10 to 40 [mm], more preferably 15 to 30 [mm].
 このような充填材8Aは、骨補填材(生体材料)として用いられる材料の粉体と、硬化用の液剤とを練和してなるものである。なお、ここでいう「粉体」とは、粉粒体、顆粒、微小な薄片または針状体等を含む広い概念であり、その形状や形態、製造方法等は特に限定されない。 Such a filler 8A is obtained by kneading a powder of a material used as a bone filling material (biological material) and a hardening liquid. The “powder” here is a broad concept including powders, granules, fine flakes, needles, etc., and the shape, form, manufacturing method, etc. are not particularly limited.
 このような粉体としては、例えば、リン酸カルシウム系化合物等による粉体が好ましい。リン酸カルシウム系化合物は、生体内で長期間安定に存在することができ、生体材料として特に優れている。 As such a powder, for example, a powder made of a calcium phosphate compound or the like is preferable. Calcium phosphate compounds can be stably present in a living body for a long period of time, and are particularly excellent as a biomaterial.
 リン酸カルシウム系化合物としては、例えば、ハイドロキシアパタイト(Ca10(PO46(OH)2)、TCP(Ca3(PO42)、Ca227、Ca(PO32、Ca10(PO462、Ca10(PO46Cl2、DCPD(CaHPO4・2H2O)、Ca4O(PO42等が挙げられ、これらのうち1種または2種以上を混合して用いることができる。 Examples of calcium phosphate compounds include hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 ), TCP (Ca 3 (PO 4 ) 2 ), Ca 2 P 2 O 7 , Ca (PO 3 ) 2 , and Ca. 10 (PO 4 ) 6 F 2 , Ca 10 (PO 4 ) 6 Cl 2 , DCPD (CaHPO 4 .2H 2 O), Ca 4 O (PO 4 ) 2, etc., one or two of these The above can be mixed and used.
 また、粉体の平均粒径は、特に限定されないが、通常、1~50μm程度であるのが好ましく、4~30μm程度であるのがより好ましい。 The average particle size of the powder is not particularly limited, but is usually preferably about 1 to 50 μm, more preferably about 4 to 30 μm.
 液剤としては、特に限定されないが、例えば、注射用水等が挙げられる。液剤には、例えば、コンドロイチン硫酸ナトリウム、コハク酸二ナトリウム無水物、亜硫酸水素ナトリウム等の添加剤を加えてもよい。 Although it does not specifically limit as a liquid agent, For example, the water for injection etc. are mentioned. For example, additives such as sodium chondroitin sulfate, disodium succinate anhydride, sodium hydrogen sulfite and the like may be added to the liquid agent.
 そして、粉体と液剤とを練和することにより、その練成体(練和物)は、経時的に硬化して硬化体となる。 Then, by kneading the powder and the liquid, the kneaded product (kneaded product) is cured with time to become a cured product.
 次に、手術用具1について説明する。
 手術用具1は、袋体2と管状部3とで構成されている。
Next, the surgical tool 1 will be described.
The surgical tool 1 includes a bag body 2 and a tubular portion 3.
 図1、図2に示すように、袋体2は、複数本の線状体22を交差させてメッシュ状に形成した編組体で構成されている。その織り方(編み方)としては、特に限定されないが、例えば、平織り、綾織り、朱子織、からみ織、模紗織、メリヤス編み、たて編み、スリーブ、ステッチまたはこれらを組み合わせた織り方が挙げられる。 As shown in FIGS. 1 and 2, the bag body 2 is formed of a braided body formed in a mesh shape by intersecting a plurality of linear bodies 22. The weaving method (knitting method) is not particularly limited, and examples include plain weaving, twill weaving, satin weaving, leash weaving, imitation weaving, knitting, warp knitting, sleeves, stitches, or a combination of these. It is done.
 そして、このメッシュ状をなす袋体2は、本発明において必須の要件ではないが、目開きの度合いが異なる大目開き部24と小目開き部25とを有するのが好ましい。すなわち、線状体22同士の間に形成される細孔23の配設密度が「疎」の部分と「密」の部分とを有するのが好ましい。なお、袋体2での目開きの大きさを変える方法としては、特に限定されないが、例えば、前述した織り方を適宜変更する方法、線状体22の太さを大目開き部24と小目開き部25とで変更する方法、大目開き部24では1枚のメッシュ状の編組体を使用し、小目開き部25では2枚のメッシュ状の編組体を重ね合わせて使用する方法等が挙げられる。なお、袋体2はメッシュ状に限らず、バルーン状であってもよい。 And although this mesh-shaped bag body 2 is not an essential requirement in the present invention, it is preferable to have a large opening portion 24 and a small opening portion 25 having different opening degrees. That is, it is preferable that the arrangement density of the pores 23 formed between the linear bodies 22 has a “sparse” portion and a “dense” portion. The method for changing the size of the opening in the bag body 2 is not particularly limited. For example, the method for appropriately changing the above-described weaving method, the thickness of the linear body 22 is set smaller than that for the large opening portion 24. A method of changing between the mesh openings 25, a method of using a single mesh braid for the large mesh opening 24, and a method of using two mesh braids superimposed on the small mesh opening 25, etc. Is mentioned. The bag body 2 is not limited to a mesh shape, and may be a balloon shape.
 また、袋体2は、図1に示す自然状態で扁平形状をなし、図2に示す使用状態、すなわち、充填材8Aが充填された状態でも、その充填された分だけ膨張して扁平形状を維持する。特に、図2に示す使用状態での外形形状は、椎体91のおおよそ決まっている空洞911の形状に近似している。さらに、扁平形状の厚さ方向に位置する両面側(図3中の上下方向)にそれぞれ大目開き部24が配置され、側面側(図3中の左右方向)に小目開き部25が配置されている。このような外形形状と各目開き部の配置とにより、袋体2は、後述する大目開き部24を椎体91の目的部位、すなわち、椎体91に対し大目開き部24を宛がいたい部分に確実に宛がうことができ、小目開き部25を椎体91の他の目的部位、すなわち、椎体91に対し小目開き部25を宛がいたい部分に確実に宛がうことができる。 Further, the bag body 2 has a flat shape in the natural state shown in FIG. 1, and even in the use state shown in FIG. 2, that is, in a state in which the filler 8 </ b> A is filled, the bag body 2 expands to the flat shape. maintain. In particular, the outer shape in the use state shown in FIG. 2 approximates the shape of the cavity 911 that is roughly determined in the vertebral body 91. Further, large opening portions 24 are arranged on both sides (vertical direction in FIG. 3) located in the thickness direction of the flat shape, and small opening portions 25 are arranged on the side surfaces (left and right direction in FIG. 3). Has been. With such an outer shape and the arrangement of each opening portion, the bag body 2 directs the large opening portion 24 described later to the target portion of the vertebral body 91, that is, the large opening portion 24 with respect to the vertebral body 91. The small opening portion 25 can be surely addressed to the desired portion, and the small opening portion 25 is surely directed to the other target portion of the vertebral body 91, that is, the portion where the small opening portion 25 is intended to be directed to the vertebral body 91. be able to.
 大目開き部24は、その目開きの大きさ、すなわち、細孔23の大きさが袋体2のなかでも比較的大の部分である。一方、小目開き部25は、その目開きの大きさが袋体2のなかでも比較的小の部分、すなわち、大目開き部24よりも目開きが小の部分である。 The large opening portion 24 is a relatively large portion of the bag body 2 in the size of the opening, that is, the size of the pores 23. On the other hand, the small opening portion 25 is a portion having a relatively small opening size in the bag body 2, that is, a portion having a smaller opening than the large opening portion 24.
 大目開き部24の目開き(細孔23)と小目開き部25の目開き(細孔23)との大小関係としては、例えば、使用前の状態で、大目開き部24の目開き(細孔23)の大きさが小目開き部25の目開き(細孔23)の2~50倍であるのが好ましく、5~20倍であるのがより好ましい。具体的には、大目開き部24の目開きは、0.05~9mmであるのが好ましく、0.5~5mmであるのがより好ましい。小目開き部25の目開きは、0.005~5mmであるのが好ましく、0.1~1mmであるのがより好ましい。 The size relationship between the opening (pore 23) of the large opening portion 24 and the opening (pore 23) of the small opening portion 25 is, for example, the opening of the large opening portion 24 in a state before use. The size of the (pore 23) is preferably 2 to 50 times the opening (pore 23) of the small opening portion 25, and more preferably 5 to 20 times. Specifically, the opening of the large opening portion 24 is preferably 0.05 to 9 mm, and more preferably 0.5 to 5 mm. The opening of the small opening portion 25 is preferably 0.005 to 5 mm, and more preferably 0.1 to 1 mm.
 このように大目開き部24および小目開き部25の各目開きの大きさがそれぞれ設定されていることにより、図3(a)に示すように、充填材8Aは、大目開き部24では、その各細孔23からの通過が確実に許容され、小目開き部25では、その各細孔23からの通過が確実に阻止(または抑制)される。これにより、使用状態では、充填材8Aは、小目開き部25よりも大目開き部24で優先的に椎体91と接することができる。換言すれば、使用状態では、充填材8Aは、大目開き部24での椎体91との接触面積が、小目開き部25での椎体91との接触面積よりも大となる。 Since the size of each opening of the large opening portion 24 and the small opening portion 25 is set as described above, the filler 8A is made of the large opening portion 24 as shown in FIG. Then, the passage from each of the pores 23 is reliably permitted, and the passage through each of the pores 23 is reliably prevented (or suppressed) in the small opening portion 25. Thereby, in the use state, the filler 8 </ b> A can preferentially contact the vertebral body 91 at the large opening portion 24 rather than the small opening portion 25. In other words, in the use state, the contact area of the filler 8A with the vertebral body 91 at the large opening portion 24 is larger than the contact area with the vertebral body 91 at the small opening portion 25.
 ところで、椎体91には、人体が直立した状態で上下方向にそれぞれ位置する終板骨(円盤状の骨)912と、2つの終板骨912の間に位置し、これらを連結する側壁を構成する骨913とがある。そして、椎体圧迫骨折整復術を施す場合、各終板骨912(接触可能部)には、充填材8Aをできるだけ接触させたく、側壁を構成する骨913(接触抑止部)には、充填材8Aとの接触をできるだけ抑止したい。その理由としては、側壁を構成する骨913は、終板骨に比べて骨折線が生じ易く、かかる側壁を構成する骨913に骨折線が生じた場合、骨折線から漏出した充填材8Aが、付近に存在する脊髄や神経根に接触する恐れがあるためである。また、終板骨912と充填材8Aとの接触を行ないたい理由としては、その接触が行なわれれば、充填材8Aと終板骨912とが接合(癒合)して、充填状態の手術用具1を椎体91の空洞911内で安定させることができるためである。 By the way, the vertebral body 91 includes end plate bones (disk-like bones) 912 positioned in the vertical direction in a state where the human body is upright, and a side wall that connects the two end plate bones 912 and connects them. There is a bone 913 that constitutes it. When performing vertebral body compression fracture reduction, each end plate bone 912 (contactable portion) is desired to be brought into contact with the filler 8A as much as possible, and the bone 913 (contact deterring portion) constituting the side wall is filled with the filler. I want to suppress contact with 8A as much as possible. The reason is that the bone 913 constituting the side wall is more likely to have a fracture line than the end plate bone, and when the fracture line is generated in the bone 913 constituting the side wall, the filler 8A leaked from the fracture line is This is because there is a risk of coming into contact with the spinal cord and nerve roots in the vicinity. Further, the reason for making contact between the end plate bone 912 and the filling material 8A is that if the contact is made, the filling material 8A and the end plate bone 912 are joined (healed), and the operation tool 1 in the filled state is obtained. This is because it can be stabilized in the cavity 911 of the vertebral body 91.
 そこで、手術用具1は、袋体2が前述したような形状をなしていることにより、椎体91の空洞911に挿入して充填材8Aを充填しさえすれば、当該充填材8Aが袋体2をその内側から押し広げ、終板骨912には大目開き部24が確実に宛がわれ(臨み)、側壁を構成する骨913には小目開き部25が確実に宛がわれることとなる(図13参照)。そして、充填材8Aは、大目開き部24の細孔23を通過して、終板骨912と接するが、小目開き部25では通過が阻止され、側壁を構成する骨913との接触が防止される(図3(a)参照)。このように、手術用具1では、袋体2内の充填材8Aが椎体91の終板骨912および側壁を構成する骨913のうちの終板骨912(所望の部位)に優先的に接することができる。これにより、充填材8Aと終板骨912とが癒合して、充填状態の手術用具1が椎体91の空洞911内で確実に安定する。また、小目開き部25での充填材8Aの不本意な漏出を防止することができる。これにより、充填材8Aが、側壁を構成する骨(脊柱管)にある脊髄やその近傍に存在する神経根等と接触するのを確実に防止することができる。 Therefore, the surgical tool 1 has the shape as described above, so that the filler 8A can be inserted into the cavity 911 of the vertebral body 91 and filled with the filler 8A. 2 is spread from the inside, and the large opening portion 24 is surely addressed (appears) to the end plate bone 912, and the small opening portion 25 is surely addressed to the bone 913 constituting the side wall. (See FIG. 13). The filler 8A passes through the pores 23 of the large opening portion 24 and comes into contact with the end plate bone 912. However, the small opening portion 25 is blocked from passing, and contact with the bone 913 constituting the side wall is prevented. This is prevented (see FIG. 3A). As described above, in the surgical instrument 1, the filler 8A in the bag body 2 preferentially contacts the end plate bone 912 of the vertebral body 91 and the end plate bone 912 (desired portion) of the bone 913 constituting the side wall. be able to. As a result, the filling material 8A and the end plate bone 912 are fused, and the surgical tool 1 in the filled state is reliably stabilized in the cavity 911 of the vertebral body 91. In addition, unintentional leakage of the filler 8A at the small openings 25 can be prevented. Thereby, it is possible to reliably prevent the filler 8A from coming into contact with the spinal cord in the bone (vertebral canal) constituting the side wall or the nerve root existing in the vicinity thereof.
 さて、本発明の手術用具1は、生体吸収性の部位および生体非吸収性の部位を備える。細孔23の大きさは、袋体2全体にわたってほぼ均一であってもよい。この場合は、生体吸収性の部位は、生体に吸収されることによって、経時的には大目開き部24になる。経時的に大目開き部24になることで、つまり、患部適用の初期においては細孔23を小さく設定できるので、充填材8Aとしてペースト状のものを使用する場合、ペーストが硬化するまでの期間、袋体2外へのペーストの漏出を防げる。ペースト硬化後には袋体2の所望の部位である生体吸収性の部位が吸収される。また、大目開き部24は、その全体(または少なくとも60%の部分)が生体吸収性(生分解性)を有する材料からなり、これに対し、小目開き部25は、その全体(または少なくとも60%の部分)が生体への吸収が抑止または防止される生体非吸収性を有する材料からなるものであってもよい。 Now, the surgical tool 1 of the present invention includes a bioabsorbable part and a non-bioabsorbable part. The size of the pores 23 may be substantially uniform over the entire bag body 2. In this case, the bioabsorbable portion becomes a large opening portion 24 over time by being absorbed by the living body. Since the pores 23 can be set small in the initial stage of application of the affected area by becoming the large opening portion 24 with time, when a paste-like material is used as the filler 8A, the period until the paste is cured The leakage of the paste to the outside of the bag body 2 can be prevented. After the paste is cured, the bioabsorbable part, which is a desired part of the bag body 2, is absorbed. The large opening portion 24 is made of a material having the whole (or at least 60% portion) having bioabsorbability (biodegradability), whereas the small opening portion 25 is made of the whole (or at least at least 60%). 60% portion) may be made of a material having non-biological absorbability that prevents or prevents absorption by the living body.
 生体吸収性を有する材料(以下「第1の材料」と言う)としては、特に限定されず、例えば、ポリ-L-ラクチド(PLLA)、ポリ-D-ラクチド(PDLA)、ポリ-D,L-ラクチド(P-D,L-LA)、ポリグリコール酸、ポリカプロラクトン、ポリジオキサノン、L-ラクチド/グリコライド共重合体、D-ラクチド/グリコライド共重合体、L-およびD-ラクチド/グリコライド共重合体(P(LA/GA))、L-ラクチド/カプロラクトン共重合体、D-ラクチド/カプロラクトン共重合体、L-およびD-ラクチド/カプロラクトン共重合体(P(LA/CL))からなる群から選択された少なくとも1種を用いることができる。この場合、大目開き部24を編成する互いに交差する2本の線状体22の双方(または片方)を第1の材料で構成することができる。これにより、図3(a)~(c)に示すように、使用状態で、大目開き部24の各線状体22は、経時的に分解・吸収され、遂には消失する。また、その過程の途中では、各線状体22が分解・吸収された分、各細孔23の大きさが増大する。 The material having bioabsorbability (hereinafter referred to as “first material”) is not particularly limited, and examples thereof include poly-L-lactide (PLLA), poly-D-lactide (PDLA), and poly-D, L. -Lactide (PD, L-LA), polyglycolic acid, polycaprolactone, polydioxanone, L-lactide / glycolide copolymer, D-lactide / glycolide copolymer, L- and D-lactide / glycolide From copolymer (P (LA / GA)), L-lactide / caprolactone copolymer, D-lactide / caprolactone copolymer, L- and D-lactide / caprolactone copolymer (P (LA / CL)) At least one selected from the group can be used. In this case, both (or one) of the two linear bodies 22 intersecting each other that knitting the large opening portion 24 can be formed of the first material. As a result, as shown in FIGS. 3A to 3C, in the state of use, each linear body 22 of the large opening portion 24 is decomposed and absorbed with time, and finally disappears. Further, in the middle of the process, the size of each pore 23 increases by the amount that each linear body 22 is decomposed and absorbed.
 このような構成の大目開き部24が設けられていることにより、充填材8Aは、椎体91の終板骨912との接触面積が経時的に増大し、これに伴って椎体91の終板骨912との接合力も経時的に増大することとなる。これにより、充填状態の手術用具1が椎体91の空洞911内でより確実に安定する。 By providing the large opening portion 24 having such a configuration, the contact area of the filling material 8A with the end plate bone 912 of the vertebral body 91 increases with time, and accordingly, the vertebral body 91 has a contact area. The joining force with the end plate bone 912 also increases with time. As a result, the filled surgical instrument 1 is more reliably stabilized in the cavity 911 of the vertebral body 91.
 なお、椎体圧迫骨折整復術が施される椎体91では、その骨形成がなされるまでは、大目開き部24を残すのが好ましいが、骨形成後には大目開き部24は消失してもよい。大目開き部24は、このような要望を満足することができるよう構成されたものであるということができる。 In the vertebral body 91 subjected to vertebral body compression fracture reduction, it is preferable to leave the large opening portion 24 until the bone formation is performed, but the large opening portion 24 disappears after the bone formation. May be. It can be said that the large opening portion 24 is configured to satisfy such a demand.
 また、大目開き部24は、袋体2において、生体に吸収される「生体吸収部」を兼ねた(「生体吸収部」として機能する)部分であるということができる。 Further, it can be said that the large opening portion 24 is a portion in the bag body 2 that also serves as a “bioabsorbing portion” that is absorbed by the living body (functions as a “bioabsorbing portion”).
 また、大目開き部24の目開きの大きさの経時的な変化は、例えば、0.1~5%/日の割合で大きくなるのが好ましい。このような設定がなされているか否かは、例えば疑似体液(SBF(Simulated Body Fluid))や生理食塩水に「大目開き部24」のサンプルを含浸させ、当該サンプルの目開きの変化過程を観察することによって確認することができる。 Further, the change with time of the size of the opening of the large opening portion 24 is preferably increased at a rate of 0.1 to 5% / day, for example. Whether or not such a setting is made is determined by, for example, impregnating a sample of the “large opening portion 24” with a simulated body fluid (SBF (Simulated Body Fluid)) or physiological saline, and changing the opening of the sample. This can be confirmed by observation.
 一方、生体への吸収が抑止または防止される材料(以下「第2の材料」と言う)としては、特に限定されず、例えば、ポリエチレン、ポリプロピレン、ポリエステル、ポリアミド(例:ナイロン6、ナイロン46、ナイロン66、ナイロン610、ナイロン612、ナイロン11、ナイロン12、ナイロン6-12、ナイロン6-66)、または、羊毛、絹糸、リネンおよび綿糸のような天然繊維が挙げられ、これらのうちの1種または2種以上を組み合わせたものを用いることができる。この場合、小目開き部25を編成する互いに交差する2本の線状体22の双方を第2の材料で構成することができる。これにより、図3(a)~(c)に示すように、使用状態でも、小目開き部25の各線状体22は、大目開き部24の各線状体22のように経時的に分解・吸収されるのが確実に防止される。これにより、小目開き部25の細孔23の大きさが一定に維持され、よって、充填材8Aが不本意に漏出して椎体91の側壁を構成する骨913に接するのが防止された状態を、持続することができる。 On the other hand, the material (hereinafter referred to as “second material”) that is inhibited or prevented from being absorbed by the living body is not particularly limited. For example, polyethylene, polypropylene, polyester, polyamide (eg, nylon 6, nylon 46, Nylon 66, Nylon 610, Nylon 612, Nylon 11, Nylon 12, Nylon 6-12, Nylon 6-66), or natural fibers such as wool, silk, linen and cotton yarn, one of these Or what combined 2 or more types can be used. In this case, both of the two linear bodies 22 intersecting each other that knitting the small opening portion 25 can be made of the second material. As a result, as shown in FIGS. 3A to 3C, each linear body 22 of the small opening portion 25 is decomposed with time like each linear body 22 of the large opening portion 24 even in use.・ It is surely prevented from being absorbed. As a result, the size of the pores 23 of the small openings 25 is kept constant, and thus the filler 8A is prevented from leaking unintentionally and coming into contact with the bone 913 constituting the side wall of the vertebral body 91. The state can persist.
 このように小目開き部25は、袋体2において、生体への吸収が抑止または防止された「生体非吸収部」を兼ねた(「生体非吸収部」として機能する)部分であるということができる。 As described above, the small opening portion 25 is a portion of the bag body 2 that also serves as a “living body non-absorbing portion” in which absorption into the living body is suppressed or prevented (functions as a “living body non-absorbing portion”). Can do.
 以上のような構成の袋体2では、目開きに大小を有することと、生体吸収性および生体非吸収を有することとの相乗効果により、袋体2内からの充填材8Aの不本意な漏出を確実に防止することができるとともに、袋体2内の充填材8Aが椎体91の終板骨912に選択的に確実に接することができる。 In the bag body 2 configured as described above, an unintentional leakage of the filler 8A from the inside of the bag body 2 due to the synergistic effect of having a size in the opening and having bioabsorbability and non-bioabsorption. 8A can be reliably prevented, and the filler 8A in the bag body 2 can selectively and reliably contact the end plate bone 912 of the vertebral body 91.
 図1、図2に示すように、袋体2の小目開き部25には、管状部3が接続されている。管状部3は、その管路(中空部)31が袋体2の内腔部21と連通している。そして、この管路31は、袋体2の内腔部21に充填材8Aを充填するときに、当該充填材8Aが通過する流路として機能する。これにより、袋体2への充填材8Aの充填を容易かつ確実に行なうことができる。 1 and 2, the tubular portion 3 is connected to the small opening portion 25 of the bag body 2. The tubular portion 3 has a pipe line (hollow portion) 31 communicating with the lumen portion 21 of the bag body 2. The conduit 31 functions as a flow path through which the filler 8A passes when the lumen 8 of the bag 2 is filled with the filler 8A. Thereby, the bag 8 can be filled with the filler 8A easily and reliably.
 また、管状部3は、メッシュ状をなしている。管状部3の目開きは、小目開き部25の目開きよりも小さく設定されており、例えば、小目開き部25の目開きの0.1~1倍であるのが好ましい。これにより、充填材8Aを袋体2に充填する際、充填材8Aは、管状部3での漏出が確実に防止され、よって、袋体2まで確実に到達することができる。 Further, the tubular portion 3 has a mesh shape. The opening of the tubular portion 3 is set to be smaller than the opening of the small opening portion 25, and is preferably 0.1 to 1 times the opening of the small opening portion 25, for example. Thus, when filling the bag body 2 with the filler 8A, the filler 8A is reliably prevented from leaking out of the tubular portion 3, and can thus reliably reach the bag body 2.
 なお、管状部3の構成材料としては、特に限定されないが、例えば、小目開き部25の構成材料と同様のものを用いることができる。これにより、袋体2と管状部3とを編み機で一括して製造することができる。 The constituent material of the tubular portion 3 is not particularly limited, but for example, the same material as the constituent material of the small opening portion 25 can be used. Thereby, the bag body 2 and the tubular part 3 can be manufactured collectively with a knitting machine.
 次に、手術用具1の使用方法の一例について、図8~図13を参照しつつ説明する。
 [1] まず、X線透視下で、図8に示すように、椎体圧迫骨折整復術を施す椎骨9の椎弓92、92から、椎体91に向けて穿孔器20を穿刺する。これにより、椎骨9の図8中の左右両側には、各椎弓92から椎体91内にかけて、細径の孔93、93が形成される。次に、リーマ30を用いて、各孔93の内径をそれぞれ拡径する。
Next, an example of how to use the surgical tool 1 will be described with reference to FIGS.
[1] First, under X-ray fluoroscopy, as shown in FIG. 8, the perforator 20 is punctured toward the vertebral body 91 from the vertebrae 92 and 92 of the vertebra 9 to which the vertebral body compression fracture reduction is performed. As a result, small- diameter holes 93 and 93 are formed on the left and right sides of the vertebra 9 in FIG. Next, the inner diameter of each hole 93 is expanded using the reamer 30.
 [2] 次に、先端部が湾曲したキュレット40を2本用意する。そして、図9に示すように、各キュレット40をそれぞれ孔93に挿入して、椎体91内を掻爬する。 [2] Next, two curettes 40 having a curved tip are prepared. Then, as shown in FIG. 9, each curette 40 is inserted into each hole 93 and the vertebral body 91 is scraped.
 [3] 次に、図10に示すように、ラスプ50を一方の孔93に挿入して、椎体91の空洞911を清掃するとともに、椎体91に対し整復を行なう。 [3] Next, as shown in FIG. 10, the rasp 50 is inserted into one hole 93 to clean the cavity 911 of the vertebral body 91 and reduce the vertebral body 91.
 [4] 次に、予め生理食塩水Qが充填されたシリンジ60を用意する。そして、図11に示すように、シリンジ60の口部601を一方の孔93に挿入し、この状態で、椎体91の空洞911に生理食塩水Qを注入する。この注入操作は、生理食塩水Qが他方の孔93から排出されるまで行なわれる。これにより、椎体91の空洞911が洗浄される。 [4] Next, a syringe 60 preliminarily filled with physiological saline Q is prepared. Then, as shown in FIG. 11, the mouth 601 of the syringe 60 is inserted into one hole 93, and in this state, physiological saline Q is injected into the cavity 911 of the vertebral body 91. This injection operation is performed until the physiological saline Q is discharged from the other hole 93. Thereby, the cavity 911 of the vertebral body 91 is cleaned.
 [5] 次に、図12に示すように、例えば挿入用ガイド棒70を用いて、一方の孔93から椎体91の空洞911に手術用具1の袋体2を挿入する。このとき、一方の孔93には、手術用具1の管状部3を位置させる。 [5] Next, as shown in FIG. 12, the bag 2 of the surgical tool 1 is inserted into the cavity 911 of the vertebral body 91 from one hole 93 using, for example, an insertion guide rod 70. At this time, the tubular portion 3 of the surgical instrument 1 is positioned in the one hole 93.
 [6] 次に、予め充填材8Aが充填されたシリンジ10を用意する。そして、図13に示すように、シリンジ10の口部101を手術用具1の管状部3に挿入し、この状態で、手術用具1に充填材8Aを充填する。この充填操作は、袋体2の大目開き部24が椎体91の終板骨912に宛がわれ、小目開き部25が側壁を構成する骨913に宛がわれるまで行なわれる。これにより、充填材8Aが充填された手術用具1が椎体91に留置されることとなる。 [6] Next, a syringe 10 preliminarily filled with the filler 8A is prepared. And as shown in FIG. 13, the opening | mouth part 101 of the syringe 10 is inserted in the tubular part 3 of the surgical tool 1, and the surgical tool 1 is filled with the filler 8A in this state. This filling operation is performed until the large opening portion 24 of the bag body 2 is assigned to the end plate bone 912 of the vertebral body 91 and the small opening portion 25 is assigned to the bone 913 constituting the side wall. Thereby, the surgical instrument 1 filled with the filler 8A is placed in the vertebral body 91.
 <第2実施形態>
  図4は、本発明の手術用具(第2実施形態)の使用状態での経時的な変化を示す断面図、図5は、図4に示す手術用具に充填される充填材の粒度分布を示すグラフである。
Second Embodiment
FIG. 4 is a cross-sectional view showing a change over time in the usage state of the surgical instrument of the present invention (second embodiment), and FIG. 5 shows the particle size distribution of the filler filled in the surgical instrument shown in FIG. It is a graph.
 以下、これらの図を参照して本発明の手術用具の第2実施形態について説明するが、前述した実施形態との相違点を中心に説明し、同様の事項はその説明を省略する。
 本実施形態は、充填材の態様が異なること以外は前記第1実施形態と同様である。
Hereinafter, the second embodiment of the surgical instrument of the present invention will be described with reference to these drawings, but the description will focus on differences from the above-described embodiment, and the description of the same matters will be omitted.
This embodiment is the same as the first embodiment except that the aspect of the filler is different.
 図4に示すように、本実施形態では、充填材8Bは、複数の顆粒81で構成されたものである。なお、ここでいう「顆粒」とは、粉粒体、粒子、微小な薄片やブロック体または針状体等を含む広い概念であり、その形状や形態、製造方法等は特に限定されない。 As shown in FIG. 4, in the present embodiment, the filler 8 </ b> B is composed of a plurality of granules 81. Here, “granule” is a broad concept including powders, particles, fine flakes, blocks, needles, and the like, and the shape, form, production method, and the like are not particularly limited.
 また、各顆粒81は、それぞれ、例えば前記第1実施形態での充填材8Aを構成する粉体と同様の材料で構成されている。 Further, each granule 81 is made of, for example, the same material as the powder constituting the filler 8A in the first embodiment.
 また、顆粒81の平均粒径dは、特に限定されないが、例えば、0.1~10mmであるのが好ましく、1~5mmであるのがより好ましい。 The average particle diameter d of the granules 81 is not particularly limited, but is preferably 0.1 to 10 mm, for example, and more preferably 1 to 5 mm.
 そして、大目開き部24の目開きおよび小目開き部25の目開きは、それぞれ、使用前の状態で、平均粒径dよりも小さい。具体的には、大目開き部24の目開きは、平均粒径dの0.5~0.9倍であるのが好ましい。小目開き部25の目開きは、平均粒径dの0.05~0.5倍であるのが好ましい。このような数値範囲に設定することにより、図5に示すように、図中の「右側に傾斜したハッチング」の領域内の顆粒81が大目開き部24で確実に捕捉される、すなわち、大目開き部24を通過するのが防止されることが分かる。また、図5中の「左側に傾斜したハッチング」の領域内の顆粒81が小目開き部25でも確実に捕捉される、すなわち、小目開き部25を通過するのも防止されることが分かる。 Further, the opening of the large opening portion 24 and the opening of the small opening portion 25 are each smaller than the average particle diameter d in a state before use. Specifically, the opening of the large opening portion 24 is preferably 0.5 to 0.9 times the average particle diameter d. The opening of the small openings 25 is preferably 0.05 to 0.5 times the average particle diameter d. By setting to such a numerical range, as shown in FIG. 5, the granules 81 in the region of “hatching inclined to the right side” in the figure are reliably captured by the large openings 24, that is, large. It can be seen that passage through the opening 24 is prevented. Further, it can be seen that the granules 81 in the region of “hatching inclined to the left” in FIG. 5 are reliably captured even by the small openings 25, that is, are prevented from passing through the small openings 25. .
 これにより、複数の顆粒81で構成された充填材8Bであっても、大目開き部24では、充填材8Bが漏出するのが防止されつつ、椎体91の終板骨912と接触することができる。また、小目開き部25では、充填材8Bが漏出するのが防止され、椎体91の側壁を構成する骨913との接触も抑制される(図4参照)。 Thereby, even if it is the filler 8B comprised by the some granule 81, in the large opening part 24, it contacts with the endplate bone 912 of the vertebral body 91, preventing the filler 8B from leaking out. Can do. Moreover, in the small opening part 25, it is prevented that the filler 8B leaks out and contact with the bone 913 which comprises the side wall of the vertebral body 91 is also suppressed (refer FIG. 4).
 <第3実施形態>
  図6は、本発明の手術用具(第3実施形態)を構成する線状体の使用状態での経時的な変化を示す図である。
<Third Embodiment>
FIG. 6 is a diagram showing a change over time in the usage state of the linear body constituting the surgical instrument (third embodiment) of the present invention.
 以下、この図を参照して本発明の手術用具の第3実施形態について説明するが、前述した実施形態との相違点を中心に説明し、同様の事項はその説明を省略する。
 本実施形態は、線状体の構成が異なること以外は前記第1実施形態と同様である。
Hereinafter, the third embodiment of the surgical instrument of the present invention will be described with reference to this figure, but the description will focus on the differences from the above-described embodiment, and the description of the same matters will be omitted.
The present embodiment is the same as the first embodiment except that the configuration of the linear body is different.
 図6に示すように、本実施形態では、大目開き部24での各線状体22は、それぞれ、素線221と素線222とを撚り合わせてなる撚り線で構成されている。もしくは各線状体22は、複数の糸を撚らず束ねたものも含む合糸であってもよい。そして、素線221が、前述した第1の材料(生体吸収性を有する材料)で構成されている。これにより、大目開き部24では、素線221が生体吸収部として機能して、目開きの増大に寄与する。また、素線222は、第2の材料(生体への吸収が抑止または防止される材料)で構成されている。 As shown in FIG. 6, in the present embodiment, each linear body 22 in the large opening portion 24 is composed of a stranded wire formed by twisting a strand 221 and a strand 222. Alternatively, each linear body 22 may be a combined yarn including a bundle of a plurality of yarns that are not twisted. And the strand 221 is comprised with the 1st material (material which has bioabsorbability) mentioned above. Thereby, in the large opening part 24, the strand 221 functions as a bioabsorbing part, and contributes to the increase in opening. Moreover, the strand 222 is comprised with the 2nd material (material in which absorption to a biological body is suppressed or prevented).
 なお、大目開き部24での各線状体22をそれぞれ構成する素線の本数は、本実施形態では2本であるが、これに限定されず、例えば、3本以上であってもよい。この場合、少なくとも1本の素線を生体吸収性材料で構成することができる。 In addition, although the number of the strands which respectively comprise each linear body 22 in the large opening part 24 is two in this embodiment, it is not limited to this, For example, three or more may be sufficient. In this case, at least one strand can be made of a bioabsorbable material.
 <第4実施形態>
  図7は、本発明の手術用具の自然状態(未使用時)での第4実施形態を示す斜視図である。
<Fourth embodiment>
FIG. 7 is a perspective view showing a fourth embodiment in a natural state (when not in use) of the surgical instrument of the present invention.
 以下、この図を参照して本発明の手術用具の第4実施形態について説明するが、前述した実施形態との相違点を中心に説明し、同様の事項はその説明を省略する。 Hereinafter, the fourth embodiment of the surgical instrument of the present invention will be described with reference to this figure, but the description will focus on the differences from the above-described embodiment, and the description of the same matters will be omitted.
 本実施形態は、手術用具が有する袋体の構成が異なること以外は前記第1実施形態と同様である。 This embodiment is the same as the first embodiment except that the configuration of the bag body of the surgical tool is different.
 図7に示すように、本実施形態の手術用具1では、袋体2にX線透視下で視認可能なマーカ部26が設けられている。マーカ部26の設置形態としては、特に限定されないが、例えば、Ni-Ti系の超弾性合金で構成された金属線を線状体22に編み込む形態が挙げられる。その他の形態として、造影剤、例えば硫酸バリウム、フッ化バリウム、およびケイ酸バリウム、ビスマス化合物、ジルコニウム化合物、ランタン化合物、トリウム化合物、ならびに希土類金属等を含んだ繊維(ペレットに含有させる、繊維にコーティングするなど、手段を問わない)を編み込む形態も挙げられる。 As shown in FIG. 7, in the surgical instrument 1 of the present embodiment, the bag 2 is provided with a marker portion 26 that can be viewed under X-ray fluoroscopy. An installation form of the marker portion 26 is not particularly limited, and for example, a form in which a metal wire made of a Ni—Ti superelastic alloy is knitted into the linear body 22 is exemplified. Other forms include contrast agents such as barium sulfate, barium fluoride, and barium silicate, bismuth compounds, zirconium compounds, lanthanum compounds, thorium compounds, and rare earth metals, etc. There is also a form of knitting a method).
 これにより、マーカ部26に造影性をもたせることができ、よって、椎体91の空洞911での袋体2の設置状態をX線透視下で把握することができる。その結果、術時においては、袋体2の内部が密になるように充填材を導入することが容易になり、術後においては、経過観察が容易になる。 Thereby, the marker part 26 can be provided with contrast, and therefore the installation state of the bag body 2 in the cavity 911 of the vertebral body 91 can be grasped under X-ray fluoroscopy. As a result, at the time of surgery, it becomes easy to introduce the filler so that the inside of the bag body 2 is dense, and follow-up is facilitated after the surgery.
 なお、マーカ部26の配置位置としては、特に限定されないが、例えば、大目開き部24(生体吸収部)と小目開き部25(生体非吸収部)との境界部であるのが好ましい。これにより、袋体2が体内の適切な位置、方向に設置されているかどうかを、補填時や手術後の経過観察時にも確認することができる。また、マーカ部26は、袋体2の全体に配置されていてもよいし、患部に補填した際に上端、中央、下端になる部分、あるいは前方、中央、後方、あるいはこれらのうちの1つ以上を組み合わせた位置でもよい。 The arrangement position of the marker portion 26 is not particularly limited, but is preferably a boundary portion between the large opening portion 24 (biological absorption portion) and the small opening portion 25 (biological non-absorption portion), for example. This makes it possible to check whether the bag body 2 is installed at an appropriate position and direction in the body even during compensation and during follow-up after surgery. Moreover, the marker part 26 may be arrange | positioned in the whole bag body 2, and when it fills in an affected part, it will become an upper part, a center, a part which becomes a lower end, or front, center, back, or one of these. A position combining the above may also be used.
 以上、本発明の手術用具を図示の実施形態について説明したが、本発明は、これに限定されるものではなく、手術用具を構成する各部は、同様の機能を発揮し得る任意の構成のものと置換することができる。また、任意の構成物が付加されていてもよい。 As mentioned above, although the surgical tool of this invention was demonstrated about embodiment of illustration, this invention is not limited to this, Each part which comprises a surgical tool of the arbitrary structures which can exhibit the same function Can be substituted. Moreover, arbitrary components may be added.
 また、本発明の手術用具は、前記各実施形態のうちの、任意の2以上の構成(特徴)を組み合わせたものであってもよい。 Further, the surgical tool of the present invention may be a combination of any two or more configurations (features) of the above embodiments.
 また、袋体は、その全体にわたって目開きが均一のものであってもよい。
 また、袋体には、ハイドロキシアパタイトや、BMP、TGF等の骨癒合を促進する物質が含まれていてもよい。
Further, the bag may have a uniform opening throughout.
Moreover, the bag body may contain a substance that promotes bone fusion, such as hydroxyapatite, BMP, and TGF.
 本発明によれば、袋体を骨欠損部に挿入して当該袋体に充填材を充填することにより、生体吸収部が骨の所望の部位に宛がわれることとなる。そして、充填材は、術後しばらくは、前記所望の部位との接触が抑止または防止されるが、生体吸収部が吸収された後、袋体を通過して、前記所望の部位と接することができる。このように、本発明では、袋体内の充填材が前記所望の部位に優先的に接することができる。これにより、充填材と前記所望の部位とが癒合して、手術用具が骨欠損部内で確実に安定する。また、袋体の生体吸収部以外の部分では、充填材の不本意な漏出を防止することができる。したがって、本発明は、産業上の利用可能性を有する。 According to the present invention, by inserting the bag body into the bone defect portion and filling the bag body with the filler, the bioabsorbable portion is addressed to a desired site of the bone. Then, for a while after the operation, the filler is prevented or prevented from contacting the desired site, but after the bioabsorbable portion is absorbed, it can pass through the bag and contact the desired site. it can. Thus, in this invention, the filler in a bag body can contact | abut preferentially the said desired site | part. Thereby, a filler and the said desired site | part are united and a surgical tool is reliably stabilized within a bone defect part. In addition, unintentional leakage of the filler can be prevented at portions other than the bioabsorbable portion of the bag. Therefore, the present invention has industrial applicability.

Claims (10)

  1.  可撓性を有する袋体を備え、該袋体を骨欠損部あるいは骨と接する部位に挿入し、その挿入状態で前記袋体の内部に充填材を充填して使用される手術用具であって、
     前記袋体は、その少なくとも一部に生体吸収性を有する生体吸収部と、生体への吸収が抑止または防止された生体非吸収部とを備えることを特徴とする手術用具。
    A surgical tool comprising a flexible bag body, inserted into a bone defect portion or a site in contact with bone, and filled with a filler in the inserted state in the inserted state. ,
    The bag is provided with a bioabsorbable portion having bioabsorbability at least in part, and a bioabsorbable portion in which absorption into the living body is suppressed or prevented.
  2.  前記袋体は、複数本の線状体を交差させてメッシュ状に形成した編組体で構成されたものである請求項1に記載の手術用具。 2. The surgical instrument according to claim 1, wherein the bag body is configured by a braided body formed by meshing a plurality of linear bodies.
  3.  前記袋体は、使用状態で経時的に前記生体吸収部での目開きが増大する請求項2に記載の手術用具。 The surgical instrument according to claim 2, wherein the opening of the bioabsorbable portion increases with time in the use state of the bag.
  4.  互いに交差する2本の前記線状体のうちの少なくとも一方は、生体吸収性材料で構成され、前記生体吸収部として機能する請求項2または3に記載の手術用具。 The surgical instrument according to claim 2 or 3, wherein at least one of the two linear bodies intersecting each other is made of a bioabsorbable material and functions as the bioabsorbable part.
  5.  前記各線状体は、それぞれ、複数の素線を撚り合わせてなる撚り線もしくは合糸で構成されており、
     前記複数の素線のうちの少なくとも1本は、生体吸収性材料で構成され、前記生体吸収部として機能する請求項2または3に記載の手術用具。
    Each of the linear bodies is composed of a stranded wire or a combined yarn obtained by twisting a plurality of strands,
    The surgical instrument according to claim 2 or 3, wherein at least one of the plurality of strands is made of a bioabsorbable material and functions as the bioabsorbable portion.
  6.  前記生体吸収性材料は、ポリジオキサノン、ポリ-L-ラクチド(PLLA)、ポリ-D,L-ラクチド(P-D,L-LA)、ポリグリコール酸、ポリカプロラクトンからなる群から選択された少なくとも1種である請求項4または5に記載の手術用具。 The bioabsorbable material is at least one selected from the group consisting of polydioxanone, poly-L-lactide (PLLA), poly-D, L-lactide (PD, L-LA), polyglycolic acid, and polycaprolactone. The surgical instrument according to claim 4 or 5, which is a seed.
  7.  前記骨欠損部が形成された骨または骨と接する前記部位には、前記充填材とできるだけ接触させたい接触可能部と、前記充填材との接触をできるだけ抑止したい接触抑止部とがあり、
     前記接触可能部には、前記生体吸収部が宛がわれ、前記接触抑止部には、前記生体非吸収部が宛がわれる請求項1ないし6のいずれかに記載の手術用具。
    The bone formed with the bone defect part or the part that contacts the bone has a contactable part that wants to make contact with the filler as much as possible and a contact deterrent part that wants to prevent contact with the filler as much as possible.
    The surgical instrument according to any one of claims 1 to 6, wherein the bioabsorbable portion is assigned to the contactable portion, and the non-absorbable portion is assigned to the contact suppression portion.
  8.  前記袋体は、扁平形状をなし、その両面側にそれぞれ前記生体吸収部が配置され、側面側に前記生体非吸収部が配置されている請求項1ないし7のいずれかに記載の手術用具。 The surgical tool according to any one of claims 1 to 7, wherein the bag body has a flat shape, the bioabsorbable portions are disposed on both sides thereof, and the bioabsorbable portions are disposed on side surfaces.
  9.  前記袋体は、X線透視下で視認可能なマーカ部を備える請求項1ないし8のいずれかに記載の手術用具。 The surgical tool according to any one of claims 1 to 8, wherein the bag body includes a marker portion that is visible under X-ray fluoroscopy.
  10.  前記マーカ部は、前記生体吸収部と前記生体非吸収部との境界部に配置されている請求項9に記載の手術用具。 The surgical tool according to claim 9, wherein the marker portion is disposed at a boundary portion between the living body absorbing portion and the living body non-absorbing portion.
PCT/JP2012/052398 2011-02-04 2012-02-02 Implement for surgery WO2012105649A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012555954A JP5952198B2 (en) 2011-02-04 2012-02-02 Surgical tools

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011-022333 2011-02-04
JP2011022333 2011-02-04

Publications (1)

Publication Number Publication Date
WO2012105649A1 true WO2012105649A1 (en) 2012-08-09

Family

ID=46602854

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2012/052398 WO2012105649A1 (en) 2011-02-04 2012-02-02 Implement for surgery

Country Status (2)

Country Link
JP (1) JP5952198B2 (en)
WO (1) WO2012105649A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111683624A (en) * 2017-11-13 2020-09-18 外科创新联合有限公司 Mesh bag for medical implant and method of use thereof
WO2021177457A1 (en) * 2020-03-05 2021-09-10 邦夫 石川 Medical honeycomb structure and manufacturing method thereof, medical tissue reconstruction bag, and forming mold

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0461863A (en) * 1990-06-29 1992-02-27 Nissho Corp Suture material for medical use
JP2003230583A (en) * 2001-12-03 2003-08-19 Takiron Co Ltd Biological material for artificial cartilage
JP2004507319A (en) * 2000-08-28 2004-03-11 ディスク ダイナミックス、 インコーポレーティッド Artificial disc
JP2004534612A (en) * 2001-07-20 2004-11-18 ザ スピネオロジー グループ,エルエルシー Inflatable porous mesh bag device and method of use for reduction, filling, fixation and support of bone disease
US20050070930A1 (en) * 2003-09-30 2005-03-31 Gene W. Kammerer Implantable surgical mesh
US20050288797A1 (en) * 2004-06-23 2005-12-29 Warwick Mills, Inc. Controlled absorption biograft material for autologous tissue support
JP2006526486A (en) * 2003-06-05 2006-11-24 エスディージーアイ・ホールディングス・インコーポレーテッド Fusion implant and method for producing the same
JP2008259810A (en) * 2007-03-16 2008-10-30 Olympus Terumo Biomaterials Corp Unit for resetting bone fracture caused by vertebral compression
JP2010136983A (en) * 2008-12-15 2010-06-24 Olympus Terumo Biomaterials Corp Bone prosthetic material filling instrument

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571189A (en) * 1994-05-20 1996-11-05 Kuslich; Stephen D. Expandable fabric implant for stabilizing the spinal motion segment
US7465318B2 (en) * 2004-04-15 2008-12-16 Soteira, Inc. Cement-directing orthopedic implants

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0461863A (en) * 1990-06-29 1992-02-27 Nissho Corp Suture material for medical use
JP2004507319A (en) * 2000-08-28 2004-03-11 ディスク ダイナミックス、 インコーポレーティッド Artificial disc
JP2004534612A (en) * 2001-07-20 2004-11-18 ザ スピネオロジー グループ,エルエルシー Inflatable porous mesh bag device and method of use for reduction, filling, fixation and support of bone disease
JP2003230583A (en) * 2001-12-03 2003-08-19 Takiron Co Ltd Biological material for artificial cartilage
JP2006526486A (en) * 2003-06-05 2006-11-24 エスディージーアイ・ホールディングス・インコーポレーテッド Fusion implant and method for producing the same
US20050070930A1 (en) * 2003-09-30 2005-03-31 Gene W. Kammerer Implantable surgical mesh
US20050288797A1 (en) * 2004-06-23 2005-12-29 Warwick Mills, Inc. Controlled absorption biograft material for autologous tissue support
JP2008259810A (en) * 2007-03-16 2008-10-30 Olympus Terumo Biomaterials Corp Unit for resetting bone fracture caused by vertebral compression
JP2010136983A (en) * 2008-12-15 2010-06-24 Olympus Terumo Biomaterials Corp Bone prosthetic material filling instrument

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111683624A (en) * 2017-11-13 2020-09-18 外科创新联合有限公司 Mesh bag for medical implant and method of use thereof
WO2021177457A1 (en) * 2020-03-05 2021-09-10 邦夫 石川 Medical honeycomb structure and manufacturing method thereof, medical tissue reconstruction bag, and forming mold

Also Published As

Publication number Publication date
JPWO2012105649A1 (en) 2014-07-03
JP5952198B2 (en) 2016-07-13

Similar Documents

Publication Publication Date Title
CN102164563B (en) Fracture fixation systems
RU2668372C1 (en) Methods for treating degenerative bone conditions
Stubbs et al. In vivo evaluation of resorbable bone graft substitutes in a rabbit tibial defect model
US9220598B2 (en) Delivery systems, tools, and methods of use
US4365357A (en) Surgical materials suitable for use with bone cements
US20090182427A1 (en) Vertebroplasty implant with enhanced interfacial shear strength
EP3244830B1 (en) Device for tendon and ligament reconstruction
CN101754730A (en) Implantable mesh for musculoskeletal trauma, orthopedic reconstruction and soft tissue repair
KR20160135217A (en) An implantable device
JP5909197B2 (en) Surgical tools
JP2015509032A (en) Implantable biological holder
JP5952198B2 (en) Surgical tools
EP2197506B1 (en) Synthetic bone substitute, method for preparing same and method for filling a cavity in a substrate
Kujala Biocompatibility and biomechanical aspects of Nitinol shape memory metal implants
Scorsato et al. Evaluation of the degradation of two bioabsorbable interference screws: an in-vivo study in sheep
JP7114828B2 (en) Living body bag body
DE102016222602A1 (en) Implant and kits for treating a bone defect
Quinaz Viscoelastic behaviour of polyvinyl alcohol fibres reinforced with hydroxyapatite crystals for biomedical applications: a study of the effect of fibres architecture on the mechanical response
US20170304490A1 (en) Absorbable device for bone regeneration

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12742689

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2012555954

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12742689

Country of ref document: EP

Kind code of ref document: A1